James Yi Li is patent litigator proficient in a diverse range of technologies. His practice focuses on life sciences patent litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act, including contested matters involving chemistry, pharmaceuticals, and biotechnology. James also has experience litigating software and consumer electronics patents in both district court and inter partes review.
James received his law degree from Harvard Law School, cum laude, in 2015. He graduated from the University of Michigan with a B.S.E. in Biomedical Engineering, summa cum laude, and a Master of Engineering in Pharmaceutical Engineering.
Admissions
Bar Admissions
Registered to Practice
- US Patent & Trademark Office
Education
- Harvard Law School, J.D., cum laude
- University of Michigan, M.Eng., Pharmaceutical Engineering
- University of Michigan, B.S.E., Biomedical Engineering, summa cum laude
Professional Activities
Publications
- Co-Author, “AI and Life Sciences Patents: Separating Myth From Reality,” New York Law Journal (March 20, 2020)
- Co-Author (Yu J, Yu J, Mani RS, et al.), “An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression,” Cancer Cell. 2010, 17(5):443-454.
Speaker
- “Paragraph IV Patent Protection and Litigation: Addressing the Complex Challenges,” The Knowledge Group (October 3, 2019)